Página 3 - Melhores Cancro da laringe médicos - TOP-83 médicos

Mais de 30 anos em imunologia com foco em viroterapia – a Dra. Jaunalksne traz abordagens imunológicas de ponta para o tratamento do cancro.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Especializar-se em viroterapia – um campo inovador na imunologia
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna

Especializado em oncologia médica com foco em cancro da laringe – trata pacientes no Complexo Hospitalar Medical Park Antalya.

• Formado na Faculdade de Medicina da Universidade Akdeniz
• Mais de 8 anos de experiência dedicada em oncologia
• Membro da equipa especializada em oncologia do Medical Park Antalya

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Dr. Auala Hubert é um oncologista médico e radioterapeuta no Hadassah Medical Center, com 33 anos de experiência especializada.

• Possuir certificação dupla em oncologia e radioterapia
• Atuar como Chefe do Centro de Cancro Gastrointestinal
• Ser membro da Sociedade de Oncologia Clínica de Israel
• Obter o doutorado em medicina no prestigiado Hospital Universitário Hadassah, em Jerusalém

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

O Professor Kyzas é um especialista líder em cancro de cabeça e pescoço, com mais de 70 publicações altamente citadas e mais de 6.000 citações.

• Formar-se em prestigiados hospitais do Reino Unido em Cirurgia Oral e Maxilofacial
• Especializar-se em transferência de tecido livre microvascular e cirurgia reconstrutiva impressa em 3D
• Diretor Clínico de todos os serviços de oncologia no ELHT, atendendo mais de 1 milhão de pessoas
• Investigador Principal em ensaios internacionais sobre ressecção a laser em cancro de cabeça e pescoço
• Receber o prestigiado Bronze National Clinical Excellence Award

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

O Dr. Karatas traz uma vasta formação internacional em otorrinolaringologia e cirurgia de cabeça e pescoço, com especializações em toda a Europa e nos EUA.

• Formação em instituições de prestígio, incluindo a Hannover Medical School e a Ohio State University
• Membro de múltiplas sociedades profissionais, incluindo a American Academy of Otolaryngology
• Especialização em técnicas cirúrgicas avançadas para cancros da cabeça e pescoço
• Trabalho no Hospital Universitário Atlas com foco em casos complexos

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

O Professor Young Ik Son é especializado exclusivamente em oncologia otorrinolaringológica no Samsung Medical Center.

• Professor de Otorrinolaringologia com foco em câncer de laringe
• Afiliado ao Samsung Medical Center – um hospital de excelência na Coreia do Sul
• Extensa experiência no tratamento de casos laríngeos complexos

Thomas Shpitzer é um otorrinolaringologista no Assuta Medical Center, especializado em condições de cabeça e pescoço.

• Concentrar-se em casos oncológicos na otorrinolaringologia
• Tratar cancros que afetam a garganta e a laringe
• Fazer parte de uma equipa especializada num importante hospital privado

O Professor Ziv Gil chefia todo o Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço no renomado Rambam Medical Center, em Israel.

• Cirurgião experiente com foco em cancros complexos de cabeça e pescoço
• Detentor do prestigiado título académico de Professor
• Especialista no tratamento de casos avançados de cancro da laringe
• Dirigir um grande departamento hospitalar universitário com equipas de especialistas completas

O Prof. Dr. Ismet Aslan é especialista em cancros de cabeça e pescoço, com vasta investigação e experiência prática no tratamento do cancro da laringe.

• Membro da Associação Turca de Laringologia e de outros grupos profissionais de ORL
• Publicar mais de 10 artigos de investigação internacional sobre condições de ORL
• Mais de 30 anos de experiência médica no campo da ORL
• Concluir formação avançada na Universidade de Istambul

O Dr. Topcu traz experiência internacional do MD Anderson e do Sunnybrook Odette Cancer Center para o tratamento do cancro da laringe no Hospital Universitário Biruni.

• Especializar-se em cancros da cabeça e pescoço, incluindo cancro da laringe
• Formar-se em instituições de topo nos EUA e Canadá
• Ser membro da ESMO e ASCO – sociedades de oncologia líderes
• Ter mais de 15 anos de experiência em oncologia médica